Some long Covid patients are seeing improvement in persistent symptoms after taking an extended course of the antiviral drug Paxlovid.


KQED health correspondent Lesley McClurg has more on a new UCSF study.

Some long Covid patients are seeing improvement in persistent symptoms after taking an extended course of the antiviral drug Paxlovid. KQED health correspondent Lesley McClurg has more on a new UCSF study.

Breaking news from the Bay Area and throughout California.

Breaking news from the Bay Area and throughout California.

KQED On Demand

KQED NOW

KQED DYNAMIC

KQED serves the people of Northern California with a community-supported alternative to commercial media. We provide citizens with the knowledge they need to make informed decisions; convene community dialogue; bring the arts to everyone; and engage audiences to share their stories.

KQED serves the people of Northern California with a community-supported alternative to commercial media. We provide citizens with the knowledge they need to make informed decisions; convene community dialogue; bring the arts to everyone; and engage audiences to share their stories.

KQED

Paxlovid Could Provide Improvement in Symptoms for Some Long COVID Patients

KQED newscast for Wednesday, January 8, 2025 at 7:00 AM

KQED Newscast

KQED newscast for Wednesday, January 8, 2025 at 6:29 AM

KQED newscast for Wednesday, January 8, 2025 at 6:00 AM

Paxlovid Could Provide Improvement in Symptoms for Some Long COVID Patients

KQED

.css-10t7zxc{display:block;-webkit-flex:none;-ms-flex:none;flex:none;height:0.7rem;}Recent clips

Recent clips